CRISPR Therapeutics AG (CRSP)
39.57
1.21 (3.15%)
At close: Jan 15, 2025, 1:49 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| PE Ratio | -32.28 | -4.86 | 15.24 | -28.94 | 49.55 | -8.31 | -13.73 | -10.7 | -15.98 | -60.71 |
| PS Ratio | 13.36 | 7.25K | 6.30 | 18.60K | 11.44 | 438.61 | 22.89 | 48.09 | 1.67K | n/a |
| PB Ratio | 2.63 | 1.69 | 2.40 | 6.07 | 3.53 | 3.49 | 5.00 | 1.07 | -14.19 | -58 |
| P/FCF Ratio | -18.21 | -5.93 | 12.59 | -39.33 | 66.26 | -13.84 | -12.05 | -4.26 | 7.08 | -86.13 |
| P/OCF Ratio | -19.05 | -6.38 | 10.68 | -42.36 | 58.45 | -14.24 | -13.39 | -4.49 | 6.95 | -86.13 |
| OCF/S Ratio | -0.7 | -1.14K | 0.59 | -438.98 | 0.20 | -30.81 | -1.71 | -10.71 | 240.60 | n/a |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.09 | 0.04 | 0.06 | n/a | n/a | n/a | -1.32 | n/a |
| Quick Ratio | 17.54 | 15.39 | 20.17 | 18.21 | 17.29 | 16.81 | 17.12 | 14.56 | 15.44 | 0.45 |
| Current Ratio | 17.54 | 15.30 | 20.17 | 18.21 | 17.29 | 16.81 | 17.12 | 14.56 | 15.44 | 0.45 |
| Asset Turnover | 0.17 | 0.00 | 0.33 | 0.00 | 0.27 | 0.01 | 0.15 | 0.01 | 0.00 | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.46 | -238.23 | n/a |
| Return on Equity (ROE) | -0.08 | -0.35 | 0.16 | -0.21 | 0.07 | -0.42 | -0.36 | -0.1 | 0.89 | 0.96 |
| Return on Assets (ROA) | -0.07 | -0.29 | 0.14 | -0.19 | 0.06 | -0.34 | -0.25 | -0.07 | -0.16 | -4.45 |
| Return on Capital (ROIC) | -0.1 | -0.32 | 0.14 | -0.2 | 0.05 | -0.34 | -0.25 | -0.21 | -0.17 | 10.71 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 64.91% | -25.19K% | 98.03% | -49.51K% | 38.06% | -3.54K% | -70.26% | -717.93% | -4.99K% | n/a |
| Net Profit Margin | -41.38% | -149.12K% | 41.36% | -64.25K% | 23.09% | -5.28K% | -166.74% | -449.3% | -10.46K% | n/a |
| Pretax Profit Margin | -40.6% | -149.20K% | 41.57% | -64.10K% | 23.24% | -5.26K% | -162.47% | -439.93% | -10.45K% | n/a |
| Operating Profit Margin | -59.95% | -154.39K% | 40.91% | -65.27K% | 16.14% | -5.09K% | -157.69% | -1.32K% | -10.42K% | n/a |
| FCF Margin | -73.37% | -122.23K% | 50.08% | -47.28K% | 17.26% | -3.17K% | -190.04% | -1.13K% | 23.59K% | n/a |
| EBITDA Margin | -54.61% | -148.85K% | 42.87% | -63.58K% | 17.77% | -4.98K% | -150.31% | -264.68% | -10.36K% | n/a |